Haloperidol and Risperidone at high concentrations activate an in vitro inflammatory response of RAW 264.7 macrophage cells by induction of apoptosis and modification of cytokine levels

[1]  V. Mondelli,et al.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? , 2016, Psychopharmacology.

[2]  P. Taylor,et al.  Tissue-resident macrophages: then and now , 2015, Immunology.

[3]  T. Yanik,et al.  Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats , 2015, Brain Research.

[4]  M. Maes,et al.  Effects of Risperidone on Cytokine Profile in Drug-Naïve First-Episode Psychosis , 2015, The international journal of neuropsychopharmacology.

[5]  M. Marcon,et al.  Methotrexate-Related Response on Human Peripheral Blood Mononuclear Cells May Be Modulated by the Ala16Val-SOD2 Gene Polymorphism , 2014, PloS one.

[6]  L. Lv,et al.  Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia , 2014, Behavioral and Brain Functions.

[7]  Hany M. Elsheikha,et al.  Adverse effects of antipsychotics on micro-vascular endothelial cells of the human blood–brain barrier , 2014, Brain Research.

[8]  L. Fésüs,et al.  Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro. , 2014, Biochemical and biophysical research communications.

[9]  R. Kahn,et al.  Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment , 2014, Schizophrenia Research.

[10]  V. Bergink,et al.  Autoimmunity, Inflammation, and Psychosis: A Search for Peripheral Markers , 2014, Biological Psychiatry.

[11]  N. Müller Immunology of Schizophrenia , 2014, Neuroimmunomodulation.

[12]  M. Al-Amin,et al.  Effects of Antipsychotics on the Inflammatory Response System of Patients with Schizophrenia in Peripheral Blood Mononuclear Cell Cultures , 2013, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[13]  Takahiro A. Kato,et al.  Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model , 2013, Schizophrenia Research.

[14]  M. Passos-Bueno,et al.  Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  Takahiro A. Kato,et al.  Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia? , 2011, Mini reviews in medicinal chemistry.

[16]  M. D. de Campos,et al.  A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. , 2011, Clinical biochemistry.

[17]  M. Wolfert,et al.  Innate immune responses of primary murine macrophage-lineage cells and RAW 264.7 cells to ligands of Toll-like receptors 2, 3, and 4. , 2010, Comparative immunology, microbiology and infectious diseases.

[18]  S. Máñez,et al.  Bcl‐2 is a negative regulator of interleukin‐1β secretion in murine macrophages in pharmacological‐induced apoptosis , 2010, British journal of pharmacology.

[19]  M. Sagrillo,et al.  Toxicological effects of ultraviolet radiation on lymphocyte cells with different manganese superoxide dismutase Ala16Val polymorphism genotypes. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  J. Muench,et al.  Adverse effects of antipsychotic medications. , 2010, American family physician.

[21]  H. Vedder,et al.  Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro , 2010, Journal of psychopharmacology.

[22]  M. Maj,et al.  Management of schizophrenia with obesity, metabolic, and endocrinological disorders. , 2009, The Psychiatric clinics of North America.

[23]  N. Jovanović,et al.  The comorbidity of diabetes mellitus and psychiatric disorders. , 2009, Psychiatria Danubina.

[24]  D. Rouillard,et al.  Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines. , 2006, Anticancer research.

[25]  J. Darby,et al.  Risperidone dose and blood level variability: accumulation effects and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting. , 1997, Journal of clinical psychopharmacology.

[26]  R. Kahn,et al.  Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. , 2014, Schizophrenia bulletin.

[27]  O. Howes,et al.  Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics , 2013, Psychopharmacology.

[28]  Ya-Min Tsai,et al.  Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-α-directed cell apoptosis in neutrophils. , 2012, International immunopharmacology.

[29]  W. Bowen,et al.  Haloperidol disrupts Akt signalling to reveal a phosphorylation-dependent regulation of pro-apoptotic Bcl-XS function. , 2009, Cellular signalling.